SEARCH

HOME / SEARCH / Saracatinib

iGMDRD409

Canonical SMILES: CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6

InChI: InChI=1S/C27H32ClN5O5/c1-32-6-8-33(9-7-32)10-13-35-19-14-21-24(23(15-19)38-18-4-11-34-12-5-18)27(30-16-29-21)31-25-20(28)2-3-22-26(25)37-17-36-22/h2-3,14-16,18H,4-13,17H2,1H3,(H,29,30,31)

InChI Key: OUKYUETWWIPKQR-UHFFFAOYSA-N

Loading, please wait...

Standard Name	CHEMBL	Pubchem CID	DRUGBANK ID	Drug Status	Drug Type
Standard NameSaracatinib CHEMBLCHEMBL217092 Pubchem CID10302500 DRUGBANK IDDB11805 Drug StatusAlone Drug TypeSmall Molecule

Drug Class:

Antineoplastic Agents Dioxoles Enzyme Inhibitors Heterocyclic Compounds Heterocyclic Compounds, 1-Ring Heterocyclic Compounds, 2-Ring Kinase inhibitor

Drug Targets:

SRC ABL1 EGFR

Drug Pathways:

RTK signaling

Drug-model tissue-cancer distribution: Bubble Plot

Drug-gene pathway enrichments

Drug-gene GO enrichments

Drug-Gene: Aster Plot

Loading, please wait...

Gene ID	Gene Name	Model Num.
100271218	RPL7P36	1
223	ALDH9A1	1
400954	EML6	2
7514	XPO1	1

Showing 1 to 4 of 151 rows rows per page

Gene in drug-gene network: Network Plot

Models in Saracatinib

Loading, please wait...

	Model	Level	Reference ID	Tissue	Cancer	Drug	Clinical Response	Source
No matching records found

SITE

DATATYPES

CLASSFICATION

Disclaimer: iGMDR is intended for research purposes only. Its information cannot be used for emergencies or medical or professional advice.